FDA Panelists Slam Agency's Proposed Opioid Trial Design

Advisors said outcomes from an enriched enrollment study would not be broadly generalizable

Related Keywords

Michigan ,United States ,Stanford University ,California ,Massachusetts ,Ann Arbor ,North Carolina ,Palo Alto ,Boston ,Greenville ,Andrew Kolodny ,Caleb Alexander ,Markc Bicket ,Briant Bateman ,Mary Ellen Mccann ,Michael Depeau ,Mauras Mcauliffe ,Harvard Medical School ,Drug Products Advisory Committee ,University Of Michigan ,Carolina University In Greenville ,Brandeis University In Waltham ,Opioid Postmarketing Requirements Consortium ,Stanford University School Of Medicine ,Opioid Policy Research Collaborative ,Heller School For Social ,Analgesic Drug Products Advisory Committee ,Stanford University School ,East Carolina University ,Heller School ,Social Policy ,Brandeis University ,Johns Hopkins Bloomberg School ,Public Health ,Medpage Today ,